Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website

TG Therapeutics

TG Therapeutics reported $2.84M in Interest Expense on Debt for its fiscal quarter ending in March of 2023.

Interest Expense On Debt Change
Alaunos Therapeutics Inc ZIOP:US USD 853K 35K
Amgen AMGN:US USD 543M 128M
Ardelyx ARDX:US USD 1.03M 37K
Biogen BIIB:US USD 62.5M 7.7M
Gilead Sciences GILD:US USD 230M 3M
Infinity Pharmaceuticals INFI:US USD 45K 0
Intercept Pharmaceuticals ICPT:US USD 2.81M 3K
Karyopharm Therapeutics KPTI:US USD 5.76M 127K
Novartis NOVN:VX USD 211M 8M
Novavax NVAX:US USD 4.32M 285K
PTC Therapeutics PTCT:US USD 27.33M 1.43M
Puma Biotechnology PBYI:US USD 3.31M 33K
Regeneron Pharmaceuticals REGN:US USD 18M 600K
Roche Holding ROG:VX CHF 348M 92M
Spectrum Pharmaceuticals SPPI:US 943K 42K
TG Therapeutics TGTX:US USD 2.84M 18K
Verastem VSTM:US USD 769K 45K
Vertex Pharmaceuticals VRTX:US USD 11.4M 200K